SCHEMBL3181092

SCHEMBL3181092

O=C(Nc1cccc2ccccc12)NC1CCC(OCc2c(F)cccc2F)CC1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ EPHX1 P07099 1/20 0.59
▸ EPHX2 P34913 4/20 0.58
▸ KDM4E B2RXH2 4/20 0.53
▸ SIGMAR1 Q99720 1/20 0.53
▸ NPC1 O15118 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ MEN1 O00255 1/20 0.46
▸ DPP4 P27487 3/20 0.45
▸ PREP P48147 3/20 0.45
▸ DPP7 Q9UHL4 3/20 0.45
▸ ALDH1A1 P00352 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ TRPV1 Q8NER1 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3181086 1.00 EPHX1 (0.59) EPHX1EPHX2KDM4ESIGMAR1NPC1
SCHEMBL3178421 0.90 EPHX2 (0.63) EPHX2KDM4ENPC1RAB9AKMT2A
SCHEMBL3178427 0.90 EPHX2 (0.63) EPHX2KDM4ENPC1RAB9AKMT2A
SCHEMBL3181109 0.86 EPHX2 (0.59) EPHX2KDM4ENPC1RAB9AKMT2A
SCHEMBL3181113 0.86 EPHX2 (0.59) EPHX2KDM4ENPC1RAB9AKMT2A
SCHEMBL3178463 0.86 EPHX2 (0.59) EPHX2KDM4ENPC1RAB9AKMT2A
SCHEMBL3179778 0.86 EPHX2 (0.59) EPHX2KDM4ENPC1RAB9AKMT2A
SCHEMBL3179788 0.86 EPHX2 (0.59) EPHX2KDM4ENPC1RAB9AKMT2A
SCHEMBL3172840 0.86 EPHX2 (0.59) EPHX2KDM4ENPC1RAB9AKMT2A
SCHEMBL3172833 0.86 EPHX2 (0.59) EPHX2KDM4ENPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662910-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-02-16 — — US claimed
US-8476043-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-07-02 — — US disclosed
US-8476043-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-07-02 — — US disclosed
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-01-27 — — US disclosed
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-01-27 — — US disclosed
US-7662910-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase EPHX1, EPHX2, NCEH1 EPHX1 1/4885EPHX2 2/4885KDM4E 2177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback